TABLE OF CONTENTS |
December 2015 Volume 33, Issue 12 |
 |  |  |
 | Editorial News Bioentrepreneur Opinion and Comment Features News and Views Computational Biology Research Careers and Recruitment
| |
 |
|
 |
 |
| Advertisement |
 |
|
 |
| |
| Advertisement |
 |
Nature Protocols is setting the benchmark for publishing high-quality peer-reviewed protocols for biological and biomedical research, containing all the technical info you need to reproduce experiments in your own lab. Visit the Nature Protocols website to access our step-by-step guides to using and adapting research techniques from the world's leading laboratories. www.nature.com/nprot | | | |
 |
| |
Editorial | Top |
 |
 |
 |
20 years of bio-lox p1213 doi:10.1038/nbt.3438 Here's hoping that a proposed shakeup of US regulations will mean that new biotech products avoid AquaAdvantage salmon's two-decade upstream struggle to regulatory approval.
|
 |
News | Top |
 |
 |
 |
Anti-CD20 antibody wows in multiple sclerosis pp1215 - 1216 Cormac Sheridan doi:10.1038/nbt1215-1215
|
 |
 |
 |
Predictive biomarkers for checkpoints, first tests approved pp1217 - 1218 Ken Garber doi:10.1038/nbt1215-1217
|
 |
 |
 |
IBM debuts hyped 'cognitive cloud' biotech HQ in Cambridge pp1219 - 1220 Lucas Laursen doi:10.1038/nbt1215-1219
|
 |
 |
 |
23andMe protects consumers' data p1220 Laura DeFrancesco doi:10.1038/nbt1215-1220
|
 |
 |
 |
A face-lift for biotech rules begins pp1221 - 1222 Emily Waltz doi:10.1038/nbt1215-1221
|
 |
 |
 |
Tumor macrophage target fuels $1.7-billion deal p1222 Ken Garber doi:10.1038/nbt1215-1222
|
 |
 |
 |
Trade pact blow for innovative drug developers p1223 Chris Morrison doi:10.1038/nbt1215-1223
|
 |
| Advertisement |
 |
 |
Bioentrepreneur | Top |
 |
 |
 |
| Building a business |
 |
 |
 |
Share and share alike pp1224 - 1228 Samuel K Sia and Matthew P Owens doi:10.1038/nbt.3422
|
 |
Opinion and Comment | Top |
 |
 |
 |
| Correspondence |
 |
 |
 |
Trade-sale exits in different biotech sectors pp1229 - 1231 Kenneth Fernald and Eric Claassen doi:10.1038/nbt.3304
|
 |
Features | Top |
 |
 |
 |
| Patents |
 |
 |
 |
Patenting parthenotes in the US and Europe pp1232 - 1234 Vincenzo Senatore, Christopher Thomas Scott and Vittorio Sebastiano doi:10.1038/nbt.3421 The real nature of a parthenote determines its ultimate value.
|
 |
 |
 |
Recent patents in antibody engineering p1235 doi:10.1038/nbt.3430
|
 |
News and Views | Top |
 |
 |
 |
|
 |
Computational Biology | Top |
 |
 |
 |
| Analysis |
 |
 |
 |
Affinity regression predicts the recognition code of nucleic acid-binding proteins pp1242 - 1249 Raphael Pelossof, Irtisha Singh, Julie L Yang, Matthew T Weirauch, Timothy R Hughes et al. doi:10.1038/nbt.3343 The specificity of DNA- and RNA-binding proteins is predicted from primary protein sequences using a machine learning approach.
|
 |
Research | Top |
 |
 |
 |
| Articles |
 |
 |
 |
Safeguarding CRISPR-Cas9 gene drives in yeast pp1250 - 1255 James E DiCarlo, Alejandro Chavez, Sven L Dietz, Kevin M Esvelt and George M Church doi:10.1038/nbt.3412 Molecular strategies are developed to safeguard the use of CRISPR-Cas9 gene drive technology.
|
 |
 |
 |
Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors pp1256 - 1263 Jianbin Wang, Colin M Exline, Joshua J DeClercq, G Nicholas Llewellyn, Samuel B Hayward et al. doi:10.1038/nbt.3408
See also: News and Views by Santilli & Thrasher
|
 |
 |
 |
Long-term culture and expansion of primary human hepatocytes pp1264 - 1271 Gahl Levy, David Bomze, Stefan Heinz, Sarada Devi Ramachandran, Astrid Noerenberg et al. doi:10.1038/nbt.3377 Primary human hepatocytes are expanded in culture while retaining metabolic function.
|
 |
 |
 |
Evolution of translation machinery in recoded bacteria enables multi-site incorporation of nonstandard amino acids pp1272 - 1279 Miriam Amiram, Adrian D Haimovich, Chenguang Fan, Yane-Shih Wang, Hans-Rudolf Aerni et al. doi:10.1038/nbt.3372 Non-standard amino acids are incorporated into proteins at large numbers of sites using evolved translation components in recoded bacteria.
|
 |
 |
 |
| Letters |
 |
 |
 |
Soft, stretchable, fully implantable miniaturized optoelectronic systems for wireless optogenetics pp1280 - 1286 Sung Il Park, Daniel S Brenner, Gunchul Shin, Clinton D Morgan, Bryan A Copits et al. doi:10.1038/nbt.3415 Optogenetic studies of the peripheral nervous system and spinal cord are enabled by soft, wirelessly powered biocompatible devices.
|
 |
 |
 |
GFP-specific CD8 T cells enable targeted cell depletion and visualization of T-cell interactions pp1287 - 1292 Judith Agudo, Albert Ruzo, Eun Sook Park, Robert Sweeney, Veronika Kana et al. doi:10.1038/nbt.3386 T cells specific for GFP allow depletion of specific cell types in mice.
|
 |
 |
 |
Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition pp1293 - 1298 Benjamin P Kleinstiver, Michelle S Prew, Shengdar Q Tsai, Nhu T Nguyen, Ved V Topkar et al. doi:10.1038/nbt.3404 Utility of the small Staphylococcus aureus Cas9 is improved by broadening its targeting range through molecular evolution of its PAM sequence.
|
 |
Careers and Recruitment | Top |
 |
 |
 |
| People |
 |
 |
 |
People p1300 doi:10.1038/nbt.3429
|
 |
 |
| Advertisement |
 |
This special issue, the last of our 10th anniversary volume, presents a collection of articles focused on "Frontiers in chemical biology" and identifies some of the emerging scientific areas that will engage chemical biologists in the coming years.
Click here to see this issue! | | | |
 |
| |
 |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  |
|
 |
No comments:
Post a Comment